Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02451475Phase 2Completed
Phase 2, randomised trial of paroxetine in fibromyalgia (FM) (3 arms), sponsored by Mansoura University. Primary endpoint: Somatic Symptoms Scale-8 at 6 months. Started Feb 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02451475.